nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—larynx—sarcoma	0.0466	0.125	CbGeAlD
Nedocromil—CYSLTR2—hematopoietic system—sarcoma	0.0281	0.0753	CbGeAlD
Nedocromil—FPR1—hematopoietic system—sarcoma	0.0253	0.0678	CbGeAlD
Nedocromil—PTGDR—hematopoietic system—sarcoma	0.0239	0.064	CbGeAlD
Nedocromil—HSP90AA1—endothelium—sarcoma	0.0187	0.0501	CbGeAlD
Nedocromil—FPR1—lymphoid tissue—sarcoma	0.0178	0.0477	CbGeAlD
Nedocromil—FPR1—bone marrow—sarcoma	0.0162	0.0435	CbGeAlD
Nedocromil—PTGDR—bone marrow—sarcoma	0.0153	0.041	CbGeAlD
Nedocromil—HSP90AA1—mammary gland—sarcoma	0.0151	0.0404	CbGeAlD
Nedocromil—HSP90AA1—myometrium—sarcoma	0.0107	0.0286	CbGeAlD
Nedocromil—CYSLTR1—hematopoietic system—sarcoma	0.0106	0.0283	CbGeAlD
Nedocromil—HSP90AA1—embryo—sarcoma	0.0103	0.0276	CbGeAlD
Nedocromil—HSP90AA1—seminal vesicle—sarcoma	0.00967	0.0259	CbGeAlD
Nedocromil—PTGDR—lymph node—sarcoma	0.0095	0.0254	CbGeAlD
Nedocromil—CYSLTR1—smooth muscle tissue—sarcoma	0.00933	0.025	CbGeAlD
Nedocromil—HSP90AA1—hematopoietic system—sarcoma	0.00919	0.0246	CbGeAlD
Nedocromil—HSP90AA1—connective tissue—sarcoma	0.00885	0.0237	CbGeAlD
Nedocromil—HSP90AA1—smooth muscle tissue—sarcoma	0.00809	0.0217	CbGeAlD
Nedocromil—CYSLTR1—uterus—sarcoma	0.008	0.0214	CbGeAlD
Nedocromil—HSP90AA1—skin of body—sarcoma	0.00799	0.0214	CbGeAlD
Nedocromil—CYSLTR1—lymphoid tissue—sarcoma	0.00746	0.02	CbGeAlD
Nedocromil—HSP90AA1—cardiac atrium—sarcoma	0.00698	0.0187	CbGeAlD
Nedocromil—HSP90AA1—uterus—sarcoma	0.00694	0.0186	CbGeAlD
Nedocromil—CYSLTR1—bone marrow—sarcoma	0.00679	0.0182	CbGeAlD
Nedocromil—HSP90AA1—lymphoid tissue—sarcoma	0.00647	0.0173	CbGeAlD
Nedocromil—HSP90AA1—tendon—sarcoma	0.00608	0.0163	CbGeAlD
Nedocromil—HSP90AA1—bone marrow—sarcoma	0.00589	0.0158	CbGeAlD
Nedocromil—HSP90AA1—testis—sarcoma	0.00504	0.0135	CbGeAlD
Nedocromil—HSP90AA1—liver—sarcoma	0.00476	0.0127	CbGeAlD
Nedocromil—CYSLTR1—lymph node—sarcoma	0.00421	0.0113	CbGeAlD
Nedocromil—HSP90AA1—lymph node—sarcoma	0.00365	0.00977	CbGeAlD
Nedocromil—Viral infection—Mitoxantrone—sarcoma	0.00329	0.0202	CcSEcCtD
Nedocromil—Photophobia—Thiotepa—sarcoma	0.00323	0.0198	CcSEcCtD
Nedocromil—Pneumonia—Thiotepa—sarcoma	0.00193	0.0119	CcSEcCtD
Nedocromil—Pneumonia—Dactinomycin—sarcoma	0.00192	0.0118	CcSEcCtD
Nedocromil—Conjunctivitis—Thiotepa—sarcoma	0.00187	0.0115	CcSEcCtD
Nedocromil—Rash erythematous—Epirubicin—sarcoma	0.00181	0.0111	CcSEcCtD
Nedocromil—Otitis media—Epirubicin—sarcoma	0.00178	0.0109	CcSEcCtD
Nedocromil—Feeling hot—Epirubicin—sarcoma	0.00176	0.0108	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.00173	0.0106	CcSEcCtD
Nedocromil—Pneumonia—Vincristine—sarcoma	0.00172	0.0105	CcSEcCtD
Nedocromil—Stinging—Epirubicin—sarcoma	0.00171	0.0105	CcSEcCtD
Nedocromil—Pharyngitis—Dactinomycin—sarcoma	0.0017	0.0104	CcSEcCtD
Nedocromil—Dysphonia—Epirubicin—sarcoma	0.00168	0.0103	CcSEcCtD
Nedocromil—Rash erythematous—Doxorubicin—sarcoma	0.00167	0.0103	CcSEcCtD
Nedocromil—Pneumonia—Mitoxantrone—sarcoma	0.00167	0.0103	CcSEcCtD
Nedocromil—Otitis media—Doxorubicin—sarcoma	0.00165	0.0101	CcSEcCtD
Nedocromil—Feeling hot—Doxorubicin—sarcoma	0.00163	0.01	CcSEcCtD
Nedocromil—Conjunctivitis—Mitoxantrone—sarcoma	0.00161	0.00992	CcSEcCtD
Nedocromil—Stinging—Doxorubicin—sarcoma	0.00158	0.00971	CcSEcCtD
Nedocromil—Sinusitis—Mitoxantrone—sarcoma	0.00156	0.00957	CcSEcCtD
Nedocromil—Dysphonia—Doxorubicin—sarcoma	0.00156	0.00956	CcSEcCtD
Nedocromil—Viral infection—Epirubicin—sarcoma	0.00153	0.00941	CcSEcCtD
Nedocromil—Cough increased—Epirubicin—sarcoma	0.00151	0.00929	CcSEcCtD
Nedocromil—Rhinitis—Mitoxantrone—sarcoma	0.00149	0.00918	CcSEcCtD
Nedocromil—Pharyngitis—Mitoxantrone—sarcoma	0.00148	0.00909	CcSEcCtD
Nedocromil—Viral infection—Doxorubicin—sarcoma	0.00142	0.00871	CcSEcCtD
Nedocromil—Cough increased—Doxorubicin—sarcoma	0.0014	0.00859	CcSEcCtD
Nedocromil—Pneumonia—Etoposide—sarcoma	0.00139	0.00854	CcSEcCtD
Nedocromil—Leukopenia—Thiotepa—sarcoma	0.00135	0.00826	CcSEcCtD
Nedocromil—Leukopenia—Dactinomycin—sarcoma	0.00134	0.0082	CcSEcCtD
Nedocromil—Cough—Thiotepa—sarcoma	0.00131	0.00806	CcSEcCtD
Nedocromil—Dysgeusia—Mitoxantrone—sarcoma	0.00127	0.00781	CcSEcCtD
Nedocromil—Leukopenia—Vincristine—sarcoma	0.00119	0.00733	CcSEcCtD
Nedocromil—Leukopenia—Mitoxantrone—sarcoma	0.00116	0.00714	CcSEcCtD
Nedocromil—Cough—Mitoxantrone—sarcoma	0.00113	0.00696	CcSEcCtD
Nedocromil—Eczema—Epirubicin—sarcoma	0.00112	0.00687	CcSEcCtD
Nedocromil—Chest pain—Mitoxantrone—sarcoma	0.00111	0.00679	CcSEcCtD
Nedocromil—Anaphylactic shock—Vincristine—sarcoma	0.00109	0.00668	CcSEcCtD
Nedocromil—Dyspepsia—Thiotepa—sarcoma	0.00108	0.00663	CcSEcCtD
Nedocromil—Anaphylactic shock—Mitoxantrone—sarcoma	0.00106	0.00651	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Thiotepa—sarcoma	0.00106	0.0065	CcSEcCtD
Nedocromil—Fatigue—Thiotepa—sarcoma	0.00106	0.0065	CcSEcCtD
Nedocromil—Dysgeusia—Etoposide—sarcoma	0.00106	0.00649	CcSEcCtD
Nedocromil—Fatigue—Dactinomycin—sarcoma	0.00105	0.00645	CcSEcCtD
Nedocromil—Pain—Thiotepa—sarcoma	0.00105	0.00644	CcSEcCtD
Nedocromil—Pain—Dactinomycin—sarcoma	0.00104	0.00639	CcSEcCtD
Nedocromil—Eczema—Doxorubicin—sarcoma	0.00103	0.00636	CcSEcCtD
Nedocromil—Gastrointestinal pain—Thiotepa—sarcoma	0.001	0.00616	CcSEcCtD
Nedocromil—Gastrointestinal pain—Dactinomycin—sarcoma	0.000996	0.00611	CcSEcCtD
Nedocromil—Urticaria—Thiotepa—sarcoma	0.000975	0.00599	CcSEcCtD
Nedocromil—Abdominal pain—Thiotepa—sarcoma	0.00097	0.00596	CcSEcCtD
Nedocromil—Body temperature increased—Thiotepa—sarcoma	0.00097	0.00596	CcSEcCtD
Nedocromil—Leukopenia—Etoposide—sarcoma	0.000967	0.00594	CcSEcCtD
Nedocromil—Abdominal pain—Dactinomycin—sarcoma	0.000963	0.00591	CcSEcCtD
Nedocromil—Body temperature increased—Dactinomycin—sarcoma	0.000963	0.00591	CcSEcCtD
Nedocromil—Dyspnoea—Mitoxantrone—sarcoma	0.000945	0.0058	CcSEcCtD
Nedocromil—Cough—Etoposide—sarcoma	0.000942	0.00579	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Vincristine—sarcoma	0.000939	0.00577	CcSEcCtD
Nedocromil—Fatigue—Vincristine—sarcoma	0.000938	0.00576	CcSEcCtD
Nedocromil—Dyspepsia—Mitoxantrone—sarcoma	0.000933	0.00573	CcSEcCtD
Nedocromil—Pain—Vincristine—sarcoma	0.00093	0.00571	CcSEcCtD
Nedocromil—Chest pain—Etoposide—sarcoma	0.000919	0.00565	CcSEcCtD
Nedocromil—Fatigue—Mitoxantrone—sarcoma	0.000913	0.00561	CcSEcCtD
Nedocromil—Pain—Mitoxantrone—sarcoma	0.000906	0.00556	CcSEcCtD
Nedocromil—Hypersensitivity—Thiotepa—sarcoma	0.000904	0.00555	CcSEcCtD
Nedocromil—Hypersensitivity—Dactinomycin—sarcoma	0.000897	0.00551	CcSEcCtD
Nedocromil—Gastrointestinal pain—Vincristine—sarcoma	0.00089	0.00546	CcSEcCtD
Nedocromil—Anaphylactic shock—Etoposide—sarcoma	0.000881	0.00541	CcSEcCtD
Nedocromil—Asthenia—Thiotepa—sarcoma	0.00088	0.00541	CcSEcCtD
Nedocromil—Asthenia—Dactinomycin—sarcoma	0.000874	0.00537	CcSEcCtD
Nedocromil—Influenza—Epirubicin—sarcoma	0.000869	0.00533	CcSEcCtD
Nedocromil—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000866	0.00532	CcSEcCtD
Nedocromil—Eosinophilia—Epirubicin—sarcoma	0.00086	0.00528	CcSEcCtD
Nedocromil—Abdominal pain—Vincristine—sarcoma	0.00086	0.00528	CcSEcCtD
Nedocromil—Body temperature increased—Vincristine—sarcoma	0.00086	0.00528	CcSEcCtD
Nedocromil—Urticaria—Mitoxantrone—sarcoma	0.000842	0.00517	CcSEcCtD
Nedocromil—Diarrhoea—Thiotepa—sarcoma	0.000839	0.00516	CcSEcCtD
Nedocromil—Abdominal pain—Mitoxantrone—sarcoma	0.000838	0.00514	CcSEcCtD
Nedocromil—Body temperature increased—Mitoxantrone—sarcoma	0.000838	0.00514	CcSEcCtD
Nedocromil—Bronchitis—Epirubicin—sarcoma	0.000835	0.00513	CcSEcCtD
Nedocromil—Diarrhoea—Dactinomycin—sarcoma	0.000833	0.00512	CcSEcCtD
Nedocromil—Dizziness—Thiotepa—sarcoma	0.000811	0.00498	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Epirubicin—sarcoma	0.000807	0.00496	CcSEcCtD
Nedocromil—Influenza—Doxorubicin—sarcoma	0.000804	0.00494	CcSEcCtD
Nedocromil—Hypersensitivity—Vincristine—sarcoma	0.000801	0.00492	CcSEcCtD
Nedocromil—Eosinophilia—Doxorubicin—sarcoma	0.000796	0.00489	CcSEcCtD
Nedocromil—Dyspnoea—Etoposide—sarcoma	0.000786	0.00483	CcSEcCtD
Nedocromil—Hypersensitivity—Mitoxantrone—sarcoma	0.000781	0.00479	CcSEcCtD
Nedocromil—Asthenia—Vincristine—sarcoma	0.000781	0.00479	CcSEcCtD
Nedocromil—Vomiting—Thiotepa—sarcoma	0.00078	0.00479	CcSEcCtD
Nedocromil—Pneumonia—Epirubicin—sarcoma	0.000779	0.00478	CcSEcCtD
Nedocromil—Vomiting—Dactinomycin—sarcoma	0.000774	0.00475	CcSEcCtD
Nedocromil—Rash—Thiotepa—sarcoma	0.000774	0.00475	CcSEcCtD
Nedocromil—Bronchitis—Doxorubicin—sarcoma	0.000773	0.00475	CcSEcCtD
Nedocromil—Dermatitis—Thiotepa—sarcoma	0.000773	0.00475	CcSEcCtD
Nedocromil—Headache—Thiotepa—sarcoma	0.000769	0.00472	CcSEcCtD
Nedocromil—Rash—Dactinomycin—sarcoma	0.000768	0.00472	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Etoposide—sarcoma	0.000761	0.00467	CcSEcCtD
Nedocromil—Asthenia—Mitoxantrone—sarcoma	0.00076	0.00467	CcSEcCtD
Nedocromil—Fatigue—Etoposide—sarcoma	0.00076	0.00467	CcSEcCtD
Nedocromil—Pain—Etoposide—sarcoma	0.000754	0.00463	CcSEcCtD
Nedocromil—Conjunctivitis—Epirubicin—sarcoma	0.000753	0.00462	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000747	0.00459	CcSEcCtD
Nedocromil—Diarrhoea—Vincristine—sarcoma	0.000744	0.00457	CcSEcCtD
Nedocromil—Nausea—Thiotepa—sarcoma	0.000729	0.00448	CcSEcCtD
Nedocromil—Sinusitis—Epirubicin—sarcoma	0.000727	0.00446	CcSEcCtD
Nedocromil—Diarrhoea—Mitoxantrone—sarcoma	0.000725	0.00445	CcSEcCtD
Nedocromil—Nausea—Dactinomycin—sarcoma	0.000723	0.00444	CcSEcCtD
Nedocromil—Pneumonia—Doxorubicin—sarcoma	0.000721	0.00443	CcSEcCtD
Nedocromil—Gastrointestinal pain—Etoposide—sarcoma	0.000721	0.00443	CcSEcCtD
Nedocromil—Dizziness—Vincristine—sarcoma	0.000719	0.00442	CcSEcCtD
Nedocromil—Urticaria—Etoposide—sarcoma	0.0007	0.0043	CcSEcCtD
Nedocromil—Rhinitis—Epirubicin—sarcoma	0.000697	0.00428	CcSEcCtD
Nedocromil—Abdominal pain—Etoposide—sarcoma	0.000697	0.00428	CcSEcCtD
Nedocromil—Body temperature increased—Etoposide—sarcoma	0.000697	0.00428	CcSEcCtD
Nedocromil—Conjunctivitis—Doxorubicin—sarcoma	0.000697	0.00428	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—PLCG1—sarcoma	0.000693	0.00149	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VEGFC—sarcoma	0.000692	0.00149	CbGpPWpGaD
Nedocromil—Vomiting—Vincristine—sarcoma	0.000692	0.00425	CcSEcCtD
Nedocromil—Pharyngitis—Epirubicin—sarcoma	0.00069	0.00424	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—CXCR4—sarcoma	0.00069	0.00149	CbGpPWpGaD
Nedocromil—Rash—Vincristine—sarcoma	0.000686	0.00421	CcSEcCtD
Nedocromil—Dermatitis—Vincristine—sarcoma	0.000685	0.00421	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—ATF1—sarcoma	0.000683	0.00147	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ATF1—sarcoma	0.000682	0.00147	CbGpPWpGaD
Nedocromil—Headache—Vincristine—sarcoma	0.000682	0.00419	CcSEcCtD
Nedocromil—CYSLTR1—GPCR downstream signaling—CXCR4—sarcoma	0.000675	0.00146	CbGpPWpGaD
Nedocromil—Vomiting—Mitoxantrone—sarcoma	0.000674	0.00414	CcSEcCtD
Nedocromil—Sinusitis—Doxorubicin—sarcoma	0.000672	0.00413	CcSEcCtD
Nedocromil—Visual impairment—Epirubicin—sarcoma	0.00067	0.00412	CcSEcCtD
Nedocromil—HSP90AA1—Axon guidance—KDR—sarcoma	0.000669	0.00144	CbGpPWpGaD
Nedocromil—Rash—Mitoxantrone—sarcoma	0.000668	0.0041	CcSEcCtD
Nedocromil—Dermatitis—Mitoxantrone—sarcoma	0.000667	0.0041	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—CXCR4—sarcoma	0.000666	0.00144	CbGpPWpGaD
Nedocromil—Headache—Mitoxantrone—sarcoma	0.000664	0.00408	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—ATF1—sarcoma	0.000658	0.00142	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—SRC—sarcoma	0.000656	0.00141	CbGpPWpGaD
Nedocromil—Hypersensitivity—Etoposide—sarcoma	0.000649	0.00399	CcSEcCtD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—sarcoma	0.000646	0.00139	CbGpPWpGaD
Nedocromil—Nausea—Vincristine—sarcoma	0.000646	0.00397	CcSEcCtD
Nedocromil—Rhinitis—Doxorubicin—sarcoma	0.000645	0.00396	CcSEcCtD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	0.000642	0.00138	CbGpPWpGaD
Nedocromil—Pharyngitis—Doxorubicin—sarcoma	0.000639	0.00392	CcSEcCtD
Nedocromil—Asthenia—Etoposide—sarcoma	0.000632	0.00388	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—NRAS—sarcoma	0.000631	0.00136	CbGpPWpGaD
Nedocromil—Nausea—Mitoxantrone—sarcoma	0.000629	0.00386	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—CREB1—sarcoma	0.000625	0.00135	CbGpPWpGaD
Nedocromil—Visual impairment—Doxorubicin—sarcoma	0.00062	0.00381	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—CXCR4—sarcoma	0.000613	0.00132	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—HRAS—sarcoma	0.00061	0.00132	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	0.000606	0.00131	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—CREB1—sarcoma	0.000604	0.0013	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—SRC—sarcoma	0.000603	0.0013	CbGpPWpGaD
Nedocromil—Diarrhoea—Etoposide—sarcoma	0.000603	0.0037	CcSEcCtD
Nedocromil—Dysgeusia—Epirubicin—sarcoma	0.000593	0.00364	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—CD34—sarcoma	0.000592	0.00128	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—CREB1—sarcoma	0.000587	0.00127	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TLE1—sarcoma	0.000583	0.00126	CbGpPWpGaD
Nedocromil—Dizziness—Etoposide—sarcoma	0.000583	0.00358	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—NRAS—sarcoma	0.00058	0.00125	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—FOXO1—sarcoma	0.000577	0.00125	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—EGFR—sarcoma	0.000575	0.00124	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—MDM2—sarcoma	0.000572	0.00123	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TLE1—sarcoma	0.000569	0.00123	CbGpPWpGaD
Nedocromil—Vomiting—Etoposide—sarcoma	0.00056	0.00344	CcSEcCtD
Nedocromil—Rash—Etoposide—sarcoma	0.000556	0.00341	CcSEcCtD
Nedocromil—Dermatitis—Etoposide—sarcoma	0.000555	0.00341	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—FLT1—sarcoma	0.000553	0.00119	CbGpPWpGaD
Nedocromil—Headache—Etoposide—sarcoma	0.000552	0.00339	CcSEcCtD
Nedocromil—Dysgeusia—Doxorubicin—sarcoma	0.000548	0.00337	CcSEcCtD
Nedocromil—HSP90AA1—Axon guidance—MMP2—sarcoma	0.000546	0.00118	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PLCG1—sarcoma	0.000544	0.00117	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—KRAS—sarcoma	0.000543	0.00117	CbGpPWpGaD
Nedocromil—Leukopenia—Epirubicin—sarcoma	0.000542	0.00333	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—IGF1R—sarcoma	0.000535	0.00115	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—EGFR—sarcoma	0.000529	0.00114	CbGpPWpGaD
Nedocromil—Cough—Epirubicin—sarcoma	0.000528	0.00324	CcSEcCtD
Nedocromil—HSP90AA1—Disease—NPM1—sarcoma	0.000526	0.00113	CbGpPWpGaD
Nedocromil—Nausea—Etoposide—sarcoma	0.000523	0.00321	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—CXCR4—sarcoma	0.000523	0.00113	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ATF1—sarcoma	0.000517	0.00111	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IGF1R—sarcoma	0.000517	0.00111	CbGpPWpGaD
Nedocromil—Chest pain—Epirubicin—sarcoma	0.000515	0.00316	CcSEcCtD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	0.000515	0.00111	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—FOXO1—sarcoma	0.00051	0.0011	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—FOXO1—sarcoma	0.000509	0.0011	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—IL2—sarcoma	0.000509	0.0011	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PDGFRB—sarcoma	0.000509	0.0011	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PDGFRB—sarcoma	0.000508	0.0011	CbGpPWpGaD
Nedocromil—Dry mouth—Epirubicin—sarcoma	0.000504	0.0031	CcSEcCtD
Nedocromil—Leukopenia—Doxorubicin—sarcoma	0.000501	0.00308	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—PDGFRA—sarcoma	0.000501	0.00108	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PDGFRA—sarcoma	0.0005	0.00108	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—KRAS—sarcoma	0.000499	0.00108	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—JUN—sarcoma	0.000497	0.00107	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Epirubicin—sarcoma	0.000494	0.00303	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—FOXO1—sarcoma	0.000492	0.00106	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—IL2—sarcoma	0.000492	0.00106	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PDGFRB—sarcoma	0.000491	0.00106	CbGpPWpGaD
Nedocromil—Cough—Doxorubicin—sarcoma	0.000489	0.003	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—PDGFRA—sarcoma	0.000483	0.00104	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VEGFC—sarcoma	0.00048	0.00103	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—KDR—sarcoma	0.000478	0.00103	CbGpPWpGaD
Nedocromil—Chest pain—Doxorubicin—sarcoma	0.000477	0.00293	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—CREB1—sarcoma	0.000474	0.00102	CbGpPWpGaD
Nedocromil—Dry mouth—Doxorubicin—sarcoma	0.000466	0.00286	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—IL2—sarcoma	0.000462	0.000997	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—HRAS—sarcoma	0.000462	0.000996	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Doxorubicin—sarcoma	0.000457	0.00281	CcSEcCtD
Nedocromil—HSP90AA1—Disease—ENO2—sarcoma	0.000455	0.000982	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—IL2—sarcoma	0.000446	0.000963	CbGpPWpGaD
Nedocromil—Dyspnoea—Epirubicin—sarcoma	0.00044	0.0027	CcSEcCtD
Nedocromil—Dyspepsia—Epirubicin—sarcoma	0.000435	0.00267	CcSEcCtD
Nedocromil—HSP90AA1—Cellular responses to stress—VEGFA—sarcoma	0.000434	0.000937	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PTPRC—sarcoma	0.000428	0.000922	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Epirubicin—sarcoma	0.000426	0.00262	CcSEcCtD
Nedocromil—Fatigue—Epirubicin—sarcoma	0.000426	0.00262	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—HRAS—sarcoma	0.000424	0.000916	CbGpPWpGaD
Nedocromil—Pain—Epirubicin—sarcoma	0.000422	0.00259	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—KDR—sarcoma	0.000421	0.000908	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CREB1—sarcoma	0.000419	0.000903	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PLCG1—sarcoma	0.000419	0.000903	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TLE1—sarcoma	0.000408	0.00088	CbGpPWpGaD
Nedocromil—Dyspnoea—Doxorubicin—sarcoma	0.000407	0.0025	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—KDR—sarcoma	0.000407	0.000877	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IGF1R—sarcoma	0.000405	0.000874	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Epirubicin—sarcoma	0.000404	0.00248	CcSEcCtD
Nedocromil—Dyspepsia—Doxorubicin—sarcoma	0.000402	0.00247	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—ATF1—sarcoma	0.000398	0.000858	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000395	0.00242	CcSEcCtD
Nedocromil—Fatigue—Doxorubicin—sarcoma	0.000394	0.00242	CcSEcCtD
Nedocromil—Urticaria—Epirubicin—sarcoma	0.000392	0.00241	CcSEcCtD
Nedocromil—Pain—Doxorubicin—sarcoma	0.000391	0.0024	CcSEcCtD
Nedocromil—Body temperature increased—Epirubicin—sarcoma	0.00039	0.0024	CcSEcCtD
Nedocromil—Abdominal pain—Epirubicin—sarcoma	0.00039	0.0024	CcSEcCtD
Nedocromil—HSP90AA1—Developmental Biology—MMP2—sarcoma	0.00039	0.000841	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—KIT—sarcoma	0.000389	0.000838	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KIT—sarcoma	0.000388	0.000837	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—NRAS—sarcoma	0.000388	0.000837	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PLCG1—sarcoma	0.000386	0.000833	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—FOXO1—sarcoma	0.000386	0.000832	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—IL2—sarcoma	0.000386	0.000832	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PDGFRB—sarcoma	0.000385	0.000831	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FLT1—sarcoma	0.000384	0.000827	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ENO2—sarcoma	0.000381	0.000823	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PDGFRA—sarcoma	0.000379	0.000818	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HBA1—sarcoma	0.000379	0.000817	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—SRC—sarcoma	0.000379	0.000816	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PLCG1—sarcoma	0.000377	0.000813	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—KIT—sarcoma	0.000375	0.000808	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—NRAS—sarcoma	0.000375	0.000808	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Doxorubicin—sarcoma	0.000374	0.0023	CcSEcCtD
Nedocromil—HSP90AA1—Disease—CXCR4—sarcoma	0.000371	0.000801	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CREB1—sarcoma	0.00037	0.000798	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CREB1—sarcoma	0.000369	0.000797	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—VEGFA—sarcoma	0.000369	0.000795	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—NRAS—sarcoma	0.000364	0.000785	CbGpPWpGaD
Nedocromil—Hypersensitivity—Epirubicin—sarcoma	0.000364	0.00224	CcSEcCtD
Nedocromil—Urticaria—Doxorubicin—sarcoma	0.000363	0.00223	CcSEcCtD
Nedocromil—CYSLTR1—Signaling Pathways—CXCR4—sarcoma	0.000362	0.000781	CbGpPWpGaD
Nedocromil—Body temperature increased—Doxorubicin—sarcoma	0.000361	0.00222	CcSEcCtD
Nedocromil—Abdominal pain—Doxorubicin—sarcoma	0.000361	0.00222	CcSEcCtD
Nedocromil—CYSLTR1—Signaling Pathways—ATF1—sarcoma	0.000358	0.000772	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CREB1—sarcoma	0.000357	0.000769	CbGpPWpGaD
Nedocromil—Asthenia—Epirubicin—sarcoma	0.000354	0.00218	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—EGFR—sarcoma	0.000354	0.000762	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—IL2—sarcoma	0.00035	0.000756	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VEGFC—sarcoma	0.000344	0.000743	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—EGFR—sarcoma	0.000341	0.000736	CbGpPWpGaD
Nedocromil—Diarrhoea—Epirubicin—sarcoma	0.000338	0.00208	CcSEcCtD
Nedocromil—Hypersensitivity—Doxorubicin—sarcoma	0.000337	0.00207	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—KRAS—sarcoma	0.000334	0.00072	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—EGFR—sarcoma	0.000332	0.000716	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—CREB1—sarcoma	0.000328	0.000708	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—sarcoma	0.000328	0.000708	CbGpPWpGaD
Nedocromil—Asthenia—Doxorubicin—sarcoma	0.000328	0.00201	CcSEcCtD
Nedocromil—Dizziness—Epirubicin—sarcoma	0.000327	0.00201	CcSEcCtD
Nedocromil—HSP90AA1—Metabolism—PLCG1—sarcoma	0.000324	0.000698	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—KRAS—sarcoma	0.000323	0.000696	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MDM2—sarcoma	0.000321	0.000692	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KDR—sarcoma	0.000319	0.000688	CbGpPWpGaD
Nedocromil—Vomiting—Epirubicin—sarcoma	0.000314	0.00193	CcSEcCtD
Nedocromil—HSP90AA1—Axon guidance—KRAS—sarcoma	0.000313	0.000676	CbGpPWpGaD
Nedocromil—Diarrhoea—Doxorubicin—sarcoma	0.000313	0.00192	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CCND1—sarcoma	0.000312	0.000674	CbGpPWpGaD
Nedocromil—Rash—Epirubicin—sarcoma	0.000311	0.00191	CcSEcCtD
Nedocromil—Dermatitis—Epirubicin—sarcoma	0.000311	0.00191	CcSEcCtD
Nedocromil—Headache—Epirubicin—sarcoma	0.000309	0.0019	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—MDM2—sarcoma	0.000306	0.00066	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MDM2—sarcoma	0.000306	0.000659	CbGpPWpGaD
Nedocromil—Dizziness—Doxorubicin—sarcoma	0.000302	0.00186	CcSEcCtD
Nedocromil—HSP90AA1—Developmental Biology—CTNNB1—sarcoma	0.000299	0.000645	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—FOXO1—sarcoma	0.000297	0.000641	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PDGFRB—sarcoma	0.000296	0.000639	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MDM2—sarcoma	0.000295	0.000637	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KIT—sarcoma	0.000294	0.000634	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—NRAS—sarcoma	0.000294	0.000634	CbGpPWpGaD
Nedocromil—Nausea—Epirubicin—sarcoma	0.000293	0.0018	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—PDGFRA—sarcoma	0.000292	0.000629	CbGpPWpGaD
Nedocromil—Vomiting—Doxorubicin—sarcoma	0.000291	0.00178	CcSEcCtD
Nedocromil—Rash—Doxorubicin—sarcoma	0.000288	0.00177	CcSEcCtD
Nedocromil—Dermatitis—Doxorubicin—sarcoma	0.000288	0.00177	CcSEcCtD
Nedocromil—Headache—Doxorubicin—sarcoma	0.000286	0.00176	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—HRAS—sarcoma	0.000284	0.000612	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IGF1R—sarcoma	0.000281	0.000606	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CREB1—sarcoma	0.00028	0.000604	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CCND1—sarcoma	0.000279	0.000603	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FLT1—sarcoma	0.000275	0.000594	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FOXO1—sarcoma	0.000274	0.000591	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HRAS—sarcoma	0.000274	0.000591	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PDGFRB—sarcoma	0.000274	0.00059	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—IL2—sarcoma	0.000273	0.000589	CbGpPWpGaD
Nedocromil—Nausea—Doxorubicin—sarcoma	0.000271	0.00167	CcSEcCtD
Nedocromil—HSP90AA1—Signaling Pathways—PLCG1—sarcoma	0.000271	0.000584	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—SRC—sarcoma	0.00027	0.000583	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PDGFRA—sarcoma	0.000269	0.000581	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EGFR—sarcoma	0.000268	0.000578	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FOXO1—sarcoma	0.000267	0.000577	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—IL2—sarcoma	0.000267	0.000577	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PDGFRB—sarcoma	0.000267	0.000576	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—HRAS—sarcoma	0.000266	0.000575	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCND1—sarcoma	0.000266	0.000574	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—JUN—sarcoma	0.000266	0.000574	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—JUN—sarcoma	0.000266	0.000573	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CTNNB1—sarcoma	0.000264	0.000569	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—IL2—sarcoma	0.000264	0.000569	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CTNNB1—sarcoma	0.000264	0.000569	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—VEGFA—sarcoma	0.000263	0.000567	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PDGFRA—sarcoma	0.000263	0.000567	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCR4—sarcoma	0.00026	0.000561	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—NRAS—sarcoma	0.00026	0.00056	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCND1—sarcoma	0.000257	0.000554	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ATF1—sarcoma	0.000257	0.000554	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—JUN—sarcoma	0.000257	0.000553	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CTNNB1—sarcoma	0.000255	0.000549	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—KRAS—sarcoma	0.000253	0.000546	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MYC—sarcoma	0.000251	0.000541	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—IL2—sarcoma	0.000243	0.000524	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—SRC—sarcoma	0.000239	0.000515	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SRC—sarcoma	0.000238	0.000514	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EGFR—sarcoma	0.000237	0.000511	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VEGFA—sarcoma	0.000232	0.0005	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MDM2—sarcoma	0.000232	0.000499	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SRC—sarcoma	0.00023	0.000496	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—NRAS—sarcoma	0.00023	0.000495	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NRAS—sarcoma	0.000229	0.000494	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KIT—sarcoma	0.000226	0.000488	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VEGFA—sarcoma	0.000224	0.000483	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MYC—sarcoma	0.000224	0.000483	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—KRAS—sarcoma	0.000224	0.000482	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NRAS—sarcoma	0.000221	0.000477	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KDR—sarcoma	0.000221	0.000477	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CREB1—sarcoma	0.000215	0.000465	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HRAS—sarcoma	0.000215	0.000464	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MYC—sarcoma	0.000214	0.00046	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EGFR—sarcoma	0.000209	0.000451	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—KIT—sarcoma	0.000209	0.000451	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EGFR—sarcoma	0.000209	0.00045	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—IL2—sarcoma	0.000207	0.000446	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MYC—sarcoma	0.000206	0.000445	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KIT—sarcoma	0.000204	0.00044	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—NRAS—sarcoma	0.000204	0.00044	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCND1—sarcoma	0.000202	0.000435	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IGF1R—sarcoma	0.000202	0.000435	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EGFR—sarcoma	0.000202	0.000435	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—JUN—sarcoma	0.000201	0.000434	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CTNNB1—sarcoma	0.0002	0.000431	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CREB1—sarcoma	0.000199	0.000429	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—KRAS—sarcoma	0.000198	0.000426	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KRAS—sarcoma	0.000197	0.000425	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CREB1—sarcoma	0.000194	0.000418	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FOXO1—sarcoma	0.000192	0.000414	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PDGFRB—sarcoma	0.000192	0.000413	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—KRAS—sarcoma	0.000191	0.000411	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—HRAS—sarcoma	0.00019	0.00041	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PDGFRA—sarcoma	0.000189	0.000407	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EGFR—sarcoma	0.000186	0.000401	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—sarcoma	0.000184	0.000397	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SRC—sarcoma	0.000181	0.000389	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—MDM2—sarcoma	0.000178	0.000384	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VEGFA—sarcoma	0.000176	0.000379	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—KRAS—sarcoma	0.000175	0.000378	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—sarcoma	0.000175	0.000378	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NRAS—sarcoma	0.000174	0.000375	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—sarcoma	0.000169	0.000365	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—HRAS—sarcoma	0.000168	0.000362	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HRAS—sarcoma	0.000168	0.000362	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MDM2—sarcoma	0.000165	0.000355	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HRAS—sarcoma	0.000162	0.000349	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MYC—sarcoma	0.000162	0.000349	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MDM2—sarcoma	0.000161	0.000346	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IL2—sarcoma	0.000159	0.000343	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KDR—sarcoma	0.000159	0.000343	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EGFR—sarcoma	0.000158	0.000341	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—JUN—sarcoma	0.000155	0.000334	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CTNNB1—sarcoma	0.000154	0.000332	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KRAS—sarcoma	0.00015	0.000322	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HRAS—sarcoma	0.000149	0.000322	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KIT—sarcoma	0.000146	0.000316	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—IL2—sarcoma	0.000143	0.000309	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CTNNB1—sarcoma	0.000142	0.000306	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCND1—sarcoma	0.00014	0.000302	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—JUN—sarcoma	0.00014	0.000301	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CREB1—sarcoma	0.000139	0.0003	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—SRC—sarcoma	0.000139	0.0003	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CTNNB1—sarcoma	0.000138	0.000299	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—NRAS—sarcoma	0.000134	0.000288	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—sarcoma	0.000133	0.000287	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SRC—sarcoma	0.000128	0.000277	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HRAS—sarcoma	0.000127	0.000274	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SRC—sarcoma	0.000125	0.00027	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NRAS—sarcoma	0.000123	0.000266	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VEGFA—sarcoma	0.000122	0.000263	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EGFR—sarcoma	0.000122	0.000263	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NRAS—sarcoma	0.00012	0.00026	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MDM2—sarcoma	0.000115	0.000249	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—KRAS—sarcoma	0.000115	0.000248	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MYC—sarcoma	0.000115	0.000248	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EGFR—sarcoma	0.000112	0.000243	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MYC—sarcoma	0.000112	0.000242	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EGFR—sarcoma	0.00011	0.000237	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—KRAS—sarcoma	0.000106	0.000229	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KRAS—sarcoma	0.000104	0.000224	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—IL2—sarcoma	0.000103	0.000222	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCND1—sarcoma	0.0001	0.000216	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—JUN—sarcoma	0.0001	0.000216	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CTNNB1—sarcoma	9.94e-05	0.000214	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HRAS—sarcoma	9.78e-05	0.000211	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—sarcoma	9.21e-05	0.000199	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HRAS—sarcoma	9.03e-05	0.000195	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SRC—sarcoma	8.98e-05	0.000194	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HRAS—sarcoma	8.81e-05	0.00019	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VEGFA—sarcoma	8.75e-05	0.000189	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NRAS—sarcoma	8.64e-05	0.000186	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MYC—sarcoma	8.05e-05	0.000174	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EGFR—sarcoma	7.87e-05	0.00017	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KRAS—sarcoma	7.44e-05	0.00016	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—sarcoma	6.61e-05	0.000143	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HRAS—sarcoma	6.32e-05	0.000136	CbGpPWpGaD
